Carole J. Spangler
Corporate Officer/Principal at Clario Medical Imaging, Inc.
Carole J. Spangler active positions
| Companies | Position | Start | End |
|---|---|---|---|
Clario Medical Imaging, Inc.
 Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Career history of Carole J. Spangler
Former positions of Carole J. Spangler
| Companies | Position | Start | End |
|---|---|---|---|
| DENDREON CORPORATION | Corporate Officer/Principal | - | - |
Training of Carole J. Spangler
| The Johns Hopkins University | Doctorate Degree |
| University of Washington | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Clario Medical Imaging, Inc.
Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Carole J. Spangler
- Experience
